KAL1 (ANOS1) Mouse Monoclonal Antibody [Clone ID: OTI4B8]
CAT#: CF811916
Carrier-free (BSA/glycerol-free) KAL1 mouse monoclonal antibody,clone OTI4B8
Other products for "ANOS1"
Specifications
Product Data | |
Clone Name | OTI4B8 |
Applications | WB |
Recommended Dilution | WB 1:500 |
Reactivities | Human |
Host | Mouse |
Isotype | IgG2b |
Clonality | Monoclonal |
Immunogen | Human recombinant protein fragment corresponding to amino acids 129-373 of human KAL1(NP_000207) produced in E.coli. |
Formulation | Lyophilized powder (original buffer 1X PBS, pH 7.3, 8% trehalose) |
Reconstitution Method | For reconstitution, we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process. (OriGene recommends Zeba Spin Desalting Columns, 7KMWCO from Thermo Scientific) |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage | Store at -20°C as received. |
Stability | Stable for 12 months from date of receipt. |
Predicted Protein Size | 76.11 kDa |
Gene Name | Homo sapiens anosmin 1 (ANOS1), mRNA. |
Database Link | |
Background | Mutations in this gene cause the X-linked Kallmann syndrome. The encoded protein is similar in sequence to proteins known to function in neural cell adhesion and axonal migration. In addition, this cell surface protein is N-glycosylated and may have anti-protease activity. [provided by RefSeq, Jul 2008] |
Synonyms | ADMLX; HH1; HHA; KAL; KAL1; KALIG-1; KMS; WFDC19 |
Reference Data |
Documents
Product Manuals |
FAQs |
SDS |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.